The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, Y.
Right arrow Articles by Wilson, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, Y.
Right arrow Articles by Wilson, J. M.

The Journal of Immunology, Vol 155, Issue 5 2564-2570, Copyright © 1995 by American Association of Immunologists

ARTICLES

Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo

Y Yang and JM Wilson
Institute for Human Gene Therapy, University of Pensylvania, Philadelphia 19104, USA.

E1-deleted recombinant adenoviruses have been developed for liver- directed gene therapy because efficient gene transfer to hepatocytes can be achieved in vivo. However, these viruses also express viral proteins in hepatocytes, leading to the development of destructive immune responses. Our previous studies indicated that MHC class I- restricted C D8+CTLs are major effectors in eliminating virus-infected cells, and CD4+ cells are also necessary in developing a fully competent CTL response by secretion of IFN-gamma, which sensitizes the virus-infected hepatocytes to CTLs through up-regulation of MHC class I expression. In this study, we have used adoptive transfer techniques in combination with mice deficient in immune functions to further define the role of CD4+ cells in the primary response to adenovirus-mediated gene transfer to the liver. Our studies indicate that CD4+ cells alone are capable of destroying virus-infected hepatocytes. Adoptive transfer experiments with beta 2m- mice along with in vitro CTL assays suggest that these CD4+ can act as CTL effectors, which are MHC class I- restricted. Depletion of these CD4+ effectors in vivo leads to prolongation of adenovirus-mediated transgene expression in hepatocytes. These results suggest that class I-restricted CD4+ CTLs contribute to elimination of adenovirus-transduced hepatocytes and extend our understanding of functional importance of CD4+ cells in viral pathogenesis.


This article has been cited by other articles:


Home page
 J. Virol.Home page
J. W. Schoggins and E. Falck-Pedersen
Fiber and Penton Base Capsid Modifications Yield Diminished Adenovirus Type 5 Transduction and Proinflammatory Gene Expression with Retention of Antigen-Specific Humoral Immunity
J. Virol., November 1, 2006; 80(21): 10634 - 10644.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. Adriaansen, M. J. B. M. Vervoordeldonk, and P. P. Tak
Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes
Rheumatology, June 1, 2006; 45(6): 656 - 668.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. Jogler, D. Hoffmann, D. Theegarten, T. Grunwald, K. Uberla, and O. Wildner
Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species.
J. Virol., April 1, 2006; 80(7): 3549 - 3558.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. W. Schoggins, M. Nociari, N. Philpott, and E. Falck-Pedersen
Influence of Fiber Detargeting on Adenovirus-Mediated Innate and Adaptive Immune Activation
J. Virol., September 15, 2005; 79(18): 11627 - 11637.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. O. Yarovinsky, M. P. Mohning, M. A. Bradford, M. M. Monick, and G. W. Hunninghake
Increased Sensitivity to Staphylococcal Enterotoxin B following Adenoviral Infection
Infect. Immun., June 1, 2005; 73(6): 3375 - 3384.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J.-I. Rodriguez-Barbosa, Y. Zhao, G. Zhao, A. Ezquerra, and M. Sykes
Murine CD4 T Cells Selected in a Highly Disparate Xenogeneic Porcine Thymus Graft Do Not Show Rapid Decay in the Absence of Selecting MHC in the Periphery
J. Immunol., December 15, 2002; 169(12): 6697 - 6710.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
H.-G. Zhang, J. Xie, L. Xu, P. Yang, X. Xu, S. Sun, Y. Wang, D. T. Curiel, H.-C. Hsu, and J. D. Mountz
Hepatic DR5 Induces Apoptosis and Limits Adenovirus Gene Therapy Product Expression in the Liver
J. Virol., May 3, 2002; 76(11): 5692 - 5700.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
G. Schiedner, S. Hertel, M. Johnston, V. Biermann, V. Dries, and S. Kochanek
Variables Affecting In Vivo Performance of High-Capacity Adenovirus Vectors
J. Virol., February 15, 2002; 76(4): 1600 - 1609.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
S. A. Vorburger and K. K. Hunt
Adenoviral Gene Therapy
Oncologist, February 1, 2002; 7(1): 46 - 59.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. A. Hobbs, S. Cho, T. J. Roberts, V. Sriram, J. Zhang, M. Xu, and R. R. Brutkiewicz
Selective Loss of Natural Killer T Cells by Apoptosis following Infection with Lymphocytic Choriomeningitis Virus
J. Virol., November 15, 2001; 75(22): 10746 - 10754.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. C. M. Johansson, A.-S. Hansson, K. S. Nandakumar, J. Backlund, and R. Holmdahl
IL-10-Deficient B10.Q Mice Develop More Severe Collagen-Induced Arthritis, but Are Protected from Arthritis Induced with Anti-Type II Collagen Antibodies
J. Immunol., September 15, 2001; 167(6): 3505 - 3512.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
W.-Y. Shen, M. C. Lai, J. Beilby, N. L. Barnett, J. Liu, I. J. Constable, and P. E. Rakoczy
Combined Effect of Cyclosporine and Sirolimus on Improving the Longevity of Recombinant Adenovirus-Mediated Transgene Expression in the Retina
Arch Ophthalmol, July 1, 2001; 119(7): 1033 - 1043.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Y. Peng, E. Falck-Pedersen, and K. B. Elkon
Variation in Adenovirus Transgene Expression between BALB/c and C57BL/6 Mice Is Associated with Differences in Interleukin-12 and Gamma Interferon Production and NK Cell Activation
J. Virol., May 15, 2001; 75(10): 4540 - 4550.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
T. D. Southgate, D. Stone, J. C. Williams, P. R. Lowenstein, and M. G. Castro
Long-Term Transgene Expression within the Anterior Pituitary Gland in Situ: Impact on Circulating Hormone Levels, Cellular and Antibody-Mediated Immune Responses
Endocrinology, January 1, 2001; 142(1): 464 - 476.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
D. FAVRE, N. FERRY, and P. MOULLIER
Critical Aspects of Viral Vectors for Gene Transfer into the Kidney
J. Am. Soc. Nephrol., November 1, 2000; 11(90002): 149S - 153.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
O. Wildner and J. C. Morris
The Role of the E1B 55 kDa Gene Product in Oncolytic Adenoviral Vectors Expressing Herpes Simplex Virus-tk: Assessment of Antitumor Efficacy and Toxicity
Cancer Res., August 1, 2000; 60(15): 4167 - 4174.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
Y. Peng, E. Falck-Pedersen, and K. B. Elkon
Soluble CD8 Attenuates Cytotoxic T Cell Responses Against Replication-Defective Adenovirus Affording Transprotection of Transgenes In Vivo
J. Immunol., August 1, 2000; 165(3): 1470 - 1478.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. Xing, A. Zganiacz, J. Wang, M. Divangahi, and F. Nawaz
IL-12-Independent Th1-Type Immune Responses to Respiratory Viral Infection: Requirement of IL-18 for IFN-{gamma} Release in the Lung But Not for the Differentiation of Viral-Reactive Th1-Type Lymphocytes
J. Immunol., March 1, 2000; 164(5): 2575 - 2584.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
G. Romano, P. Micheli, C. Pacilio, and A. Giordano
Latest Developments in Gene Transfer Technology: Achievements, Perspectives, and Controversies over Therapeutic Applications
Stem Cells, January 1, 2000; 18(1): 19 - 39.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
R. M. Minter, J. E. Rectenwald, K. Fukuzuka, C. L. Tannahill, D. La Face, V. Tsai, I. Ahmed, E. Hutchins, R. Moyer, E. M. Copeland III, et al.
TNF-{alpha} Receptor Signaling and IL-10 Gene Therapy Regulate the Innate and Humoral Immune Responses to Recombinant Adenovirus in the Lung
J. Immunol., January 1, 2000; 164(1): 443 - 451.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. I. Meneses, L. E. Abrey, K. A. Hajjar, S. H. Gultekin, R. M. Duvoisin, K. I. Berns, and M. R. Rosenfeld
Simplified Production of a Recombinant Human Angiostatin Derivative That Suppresses Intracerebral Glial Tumor Growth
Clin. Cancer Res., November 1, 1999; 5(11): 3689 - 3694.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. Hartigan-O'Connor, A. Amalfitano, and J. S. Chamberlain
Improved Production of Gutted Adenovirus in Cells Expressing Adenovirus Preterminal Protein and DNA Polymerase
J. Virol., September 1, 1999; 73(9): 7835 - 7841.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
A. Harui, S. Suzuki, S. Kochanek, and K. Mitani
Frequency and Stability of Chromosomal Integration of Adenovirus Vectors
J. Virol., July 1, 1999; 73(7): 6141 - 6146.
[Abstract] [Full Text]

Home page
 GutHome page
S Wirtz, P R Galle, and M F Neurath
Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure
Gut, June 1, 1999; 44(6): 800 - 807.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. M. Moodycliffe, S. Maiti, and S. E. Ullrich
Splenic NK1.1-Negative, TCR{alpha}{beta} Intermediate CD4+ T Cells Exist in Naive NK1.1 Allelic Positive and Negative Mice, with the Capacity to Rapidly Secrete Large Amounts of IL-4 and IFN-{gamma} Upon Primary TCR Stimulation
J. Immunol., May 1, 1999; 162(9): 5156 - 5163.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Lee, J. A. Dennis, P. J. Healy, B. Mull, L. Pastore, H. Yu, E. Aguilar-Cordova, W. O'Brien, P. Reeds, and A. L. Beaudet
Hepatocyte gene therapy in a large animal: A neonatal bovine model of citrullinemia
PNAS, March 30, 1999; 96(7): 3981 - 3986.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Ma, S. Thornton, L. E. Duwel, G. P. Boivin, E. H. Giannini, J. M. Leiden, J. A. Bluestone, and R. Hirsch
Inhibition of Collagen-Induced Arthritis in Mice by Viral IL-10 Gene Transfer
J. Immunol., August 1, 1998; 161(3): 1516 - 1524.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. M. Siders, P. W. Wright, J. A. Hixon, W. G. Alvord, T. C. Back, R. H. Wiltrout, and R. G. Fenton
T Cell- and NK Cell-Independent Inhibition of Hepatic Metastases by Systemic Administration of an IL-12-Expressing Recombinant Adenovirus
J. Immunol., June 1, 1998; 160(11): 5465 - 5474.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Wakita, C. Taya, A. Katsume, J. Kato, H. Yonekawa, Y. Kanegae, I. Saito, Y. Hayashi, M. Koike, and M. Kohara
Efficient Conditional Transgene Expression in Hepatitis C Virus cDNA Transgenic Mice Mediated by the Cre/loxP System
J. Biol. Chem., April 10, 1998; 273(15): 9001 - 9006.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
V. J. Cavanaugh, L. G. Guidotti, and F. V. Chisari
Inhibition of Hepatitis B Virus Replication during Adenovirus and Cytomegalovirus Infections in Transgenic Mice
J. Virol., April 1, 1998; 72(4): 2630 - 2637.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Ogasawara, K. Takeda, W. Hashimoto, M. Satoh, R. Okuyama, N. Yanai, M. Obinata, K. Kumagai, H. Takada, H. Hiraide, et al.
Involvement of NK1+ T Cells and Their IFN-{gamma} Production in the Generalized Shwartzman Reaction
J. Immunol., April 1, 1998; 160(7): 3522 - 3527.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. Amalfitano, M. A. Hauser, H. Hu, D. Serra, C. R. Begy, and J. S. Chamberlain
Production and Characterization of Improved Adenovirus Vectors with the E1, E2b, and E3 Genes Deleted
J. Virol., February 1, 1998; 72(2): 926 - 933.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. M. Frey, S. Rafii, M. Teterson, D. Eaton, R. G. Crystal, and M. A.S. Moore
Adenovector-Mediated Expression of Human Thrombopoietin cDNA in Immune-Compromised Mice: Insights into the Pathophysiology of Osteomyelofibrosis
J. Immunol., January 15, 1998; 160(2): 691 - 699.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Arai, D. Gordon, E. G. Nabel, and G. J. Nabel
Gene transfer of Fas ligand induces tumor regression vivo
PNAS, December 9, 1997; 94(25): 13862 - 13867.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. B. Elkon, C.-C. Liu, J. G. Gall, J. Trevejo, M. W. Marino, K. A. Abrahamsen, X. Song, J.-L. Zhou, L. J. Old, R. G. Crystal, et al.
Tumor necrosis factor alpha  plays a central role in immune-mediated clearance of adenoviral vectors
PNAS, September 2, 1997; 94(18): 9814 - 9819.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. Maione, C. D. Rocca, P. Giannetti, R. D'Arrigo, L. Liberatoscioli, L. L. Franlin, V. Sandig, G. Ciliberto, N. La Monica, and R. Savino
An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus
PNAS, May 22, 2001; 98(11): 5986 - 5991.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.